Good Distribution Practice or GDP deals with the guidelines for the proper distribution of medicinal products for human use. GDP is a quality warranty system, which includes requirements for purchase, receiving, storage and export of drugs intended for human consumption.
GDP regulates the division and movement of pharmaceutical products from the premises of the manufacturer of medicinal products, or another central point, to the end user thereof, or to an intermediate point by means of various transport methods, via various storage and/or health establishments.
Legislation
- In Asia, GDP consulting and auditing service are provided by companies like PSC and SGS.
- In Europe GDP is based on the Directive of the Board of the European Community 92/25/EEC regarding the wholesale distribution of drugs for human consumption.
- In US GDP is based on the Code of Federal Regulations 21 CFR 210/211, and USP 1079.
See also
- European Medicines Agency (EMEA)
- Good Manufacturing Practice
- GxP
- Japan Ministry of Health
- Packaging and labelling
- Prescription Drug Marketing Act (PDMA) (USA)
External links
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
